Literature DB >> 11083697

Managing life-threatening hemoptysis: has anything really changed?

E F Haponik1, A Fein, R Chin.   

Abstract

STUDY
OBJECTIVES: To delineate current chest clinicians' approaches to the management of patients with life-threatening hemoptysis.
DESIGN: Survey during a computer-assisted interactive continuing medical education presentation.
SETTING: The 1998 American College of Chest Physicians (ACCP) Annual Scientific Assembly. PARTICIPANTS: Chest clinicians attending the respiratory emergency symposium.
RESULTS: Most clinicians (86%) had cared for patients with life-threatening hemoptysis, and 28% had cared for patients with fatal events during the previous year. Those clinicians favored management in the ICU setting (95%) with early endotracheal intubation (85%), and they tended to use a large-bore, single-lumen endotracheal tube (57%). The majority (64%) favored the early performance of diagnostic bronchoscopy during the first 24 h. Most clinicians (79%) used the flexible instrument, a higher frequency than respondents at a similar symposium on hemoptysis at the 1988 ACCP meeting (48%; p < 0.0001). Most current clinicians (77%) had experience with endobronchial measures to control bleeding, but few (14%) found them to be consistently worthwhile. Chest CT scanning was often helpful in diagnosis (55%). In their management of bleeding, half of these clinicians favored the use of interventional angiography, even in operable patients, which is a substantial change from 1988 when 23% had favored this approach (p < 0.0001).
CONCLUSIONS: During the past decade, life-threatening hemoptysis has remained an important problem. Flexible bronchoscopy and interventional angiography have become increasingly established, more widely accepted approaches to patient care.

Entities:  

Mesh:

Year:  2000        PMID: 11083697     DOI: 10.1378/chest.118.5.1431

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  21 in total

1.  Bronchial artery embolization for hemoptysis.

Authors:  David R Sopko; Tony P Smith
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

Review 2.  The pulmonary physician in critical care * Illustrative case 7: Assessment and management of massive haemoptysis.

Authors:  J L Lordan; A Gascoigne; P A Corris
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

3.  Double-lumen endobronchial tube and alternatives in massive hemoptysis: How do you want to save lives?

Authors:  Schaal Jean-Vivien; Dubost Clément; Tourtier Jean-Pierre; Auroy Yves
Journal:  J Emerg Trauma Shock       Date:  2011-07

4.  [Bronchial and nonbronchial systemic artery embolization in managing haemoptysis: 31 years of experience].

Authors:  G P Cornalba; A Vella; F Barbosa; G Greco; C Michelozzi; A Sacrini; F Melchiorre
Journal:  Radiol Med       Date:  2012-08-09       Impact factor: 3.469

5.  Pulmonary resection in the treatment of life-threatening hemoptysis.

Authors:  Hakan Kiral; Serdar Evman; Cagatay Tezel; Levent Alpay; Tunc Lacin; Volkan Baysungur; Irfan Yalcinkaya
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-03-02       Impact factor: 1.520

Review 6.  Diagnosis and management of hemoptysis.

Authors:  Anna Rita Larici; Paola Franchi; Mariaelena Occhipinti; Andrea Contegiacomo; Annemilia del Ciello; Lucio Calandriello; Maria Luigia Storto; Riccardo Marano; Lorenzo Bonomo
Journal:  Diagn Interv Radiol       Date:  2014 Jul-Aug       Impact factor: 2.630

Review 7.  The Diagnosis and Treatment of Hemoptysis.

Authors:  Harald Ittrich; Maximilian Bockhorn; Hans Klose; Marcel Simon
Journal:  Dtsch Arztebl Int       Date:  2017-06-05       Impact factor: 5.594

8.  [Hemoptysis].

Authors:  L Freitag; H N Macha
Journal:  Internist (Berl)       Date:  2004-05       Impact factor: 0.743

9.  Long-term outcomes of the bronchial artery embolization are diagnosis dependent.

Authors:  Vikas Pathak; Joseph M Stavas; Hubert J Ford; Charles A Austin; Robert M Aris
Journal:  Lung India       Date:  2016 Jan-Feb

Review 10.  Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts.

Authors:  M Reck; F Barlesi; L Crinò; C I Henschke; D Isla; S Stiebeler; D R Spigel
Journal:  Ann Oncol       Date:  2011-11-04       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.